Transcreener® ADP2 Assay Delivers Precise Measurement of Functional MAPK14 Residence Time
Monday, 01 May 2023
by Bellbrook Labs
Researchers at the University of Tubingen use Transcreener to uncover how residence time works on a molecular level with p38α MAPK Inhibitors – Many factors affect the effectiveness of ligand-substrate or drug-target interactions. Conformational docking and stearic considerations help inform optimal “fits.” Ligand moiety solubility, both in free and bound forms, is also a consideration
- Published in Emerging Targets, HTS Assays, Innate Immunity, Products, Success Stories
No Comments